Dabigat 150 (Dabigatran Etexilate Capsule) 150mg

Dabigat 150 contains Dabigatran Etexilate, a capsule used for blood clot prevention. It belongs to the anticoagulant class and is prescribed to reduce stroke risks. This 150mg strength medication is commonly used in post-surgery care and atrial fibrillation management.

Strength

150mg

Pack Size

6X10s

Storage

Ambient

Manufacturer / TM Owner

NATCO PHARMA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dabigatran Etexilate, the active ingredient in Dabigat 150, is primarily used to prevent blood clots in patients with atrial fibrillation or those undergoing hip or knee replacement surgery. It works by thinning the blood to reduce the risk of stroke or systemic embolism. This medication is also prescribed for deep vein thrombosis treatment and prevention of recurrent clots.

Side Effects

Dabigat 150 may help reduce the risk of blood clots forming in the body. Users often report improved circulation and a lowered chance of clot-related complications. Some may experience mild digestive discomfort, such as nausea or stomach upset, which is common with anticoagulants.

Precautions & Warnings

Store Dabigat 150 in a cool, dry place away from moisture and direct sunlight. Keep the medication in its original packaging to protect it from humidity. Always check the expiry date before use and consult a healthcare provider if you notice any unusual symptoms or side effects.

Avoid Interactions

Dabigat 150 can interact with other blood thinners, NSAIDs, or certain antibiotics, increasing bleeding risks. Avoid alcohol and grapefruit products while taking this medication, as they may affect its efficacy. Inform your doctor about all prescription and over-the-counter medications you are using.

Frequently Asked Questions

Dabigat 150 is used to prevent blood clots in patients with atrial fibrillation or after hip/knee replacement surgery.

Store Dabigat 150 in a dry place at room temperature, away from moisture and direct light.

Consult a healthcare provider before combining Dabigat 150 with other drugs, especially blood thinners or NSAIDs.

Common side effects may include nausea, stomach upset, or mild digestive discomfort.

No, Dabigat 150 requires a prescription and should be used under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.